ClinicalTrials.gg
Status unknownNCT06454877Updated Jun 12, 2024

Effect of Normothermia Care Bundle in Knee Replacement Surgery

An interventional study of active heating and pasive heating in Knee Prosthesis, sponsored by Istanbul Saglik Bilimleri University. Status unknown. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-12.

Sponsored by Istanbul Saglik Bilimleri University · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Jun 2024), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Osteoarthritis is a disease characterized by disruption of the integrity of articular cartilage as a result of erosion of articular cartilage. Knee osteoarthritis causes muscle weakness, crepitation and deformities in the knee joint, limiting the individual's movement and causing loss of function. The most prominent feature is pain. Therefore, knee replacement surgery is performed in advanced cases where pharmacologic treatment is not effective. Many complications can be seen during the operation process and some of them may occur due to hypothermia. Studies have reported that warming during the operation prevents hypothermia and reduces complications. In this study, it was aimed to examine the effect of active and passive heating applied before, during and after surgery on hypothermia, surgical site infections and bleeding. The population of the study will consist of patients who underwent knee replacement surgery in the Orthopedics and Traumatology Clinic of Üsküdar State Hospital between April 2024 and April 2025. Data will be collected using the patient identification form, normothermia care package observation form, preoperative follow-up form, postoperative follow-up form and postoperative long-term follow-up form. A randomization list generated from a computer-based random numbers table will be used to determine which group of patients will be included in the study. Patients will be followed up in 3 periods: preoperative, intraoperative and postoperative periods. The postoperative period will be evaluated in five stages as day 1, day 2, day 3, day 10 and day 30. The purpose of the study and the intervention to be applied will be explained to all groups to be included in the study by the researcher and written and verbal consent will be obtained from the volunteers. The groups included in the study will be subjected to the heating protocol according to the normothermia care package. Group A will receive active heating with the heating method using a hot air blowing device. Group B will receive passive heating using a reflective blanket. Group C was planned as a control group to be heated by applying the routine heating procedure of the hospital without any intervention. Body temperature and vital signs will be checked preoperatively and warming will be performed 30 minutes before surgery, and warming will be started 15 minutes before anesthesia induction during surgery and body temperature and vital signs will be checked. After the operation and in the ward, warming will be performed until the body temperature reaches 37 C°. The data obtained will be analyzed using SPSS (Statistical Package for Social Sciences) for Windows 22.0 program.

02

Conditions studied

  • Knee Prosthesis

Keywords

  • Hypotermia
  • surgical site infection
  • active heating
  • pasive heating
  • nursing care bundle
03

In context

Surgical Wound Infection

687 studies on the registry are indexed under Surgical Wound Infection; 142 are open to participants now.

This study's planned enrollment of 120 is below the median of 200 across 526 interventional studies indexed under Surgical Wound Infection.

Browse Surgical Wound Infection studies →

Lead sponsor

Istanbul Saglik Bilimleri University is the lead sponsor of 60 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

18 years or older Planned elective knee arthroplasty surgery Patients planned for neuraxial block anesthesia ASA (American Society of Anesthesiologists) class I-III

Exclusion criteria

Exclusion Criteria:

Alcohol and drug addiction, Patients who cannot be contacted Preoperative body temperature \<36 C° or ≥37.5 C°

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    active heating

    It is the group to be actively heated with the heating method using hot air blowing device.

    Device: active heating

  • Experimental
    pasive heating

    Passive heating using reflective blankets is the group to be made.

    Behavioral: pasive heating

  • No intervention
    control group

    The group will receive routine hospital care without any intervention.

Interventions

  • Deviceactive heating

    Preheating will be performed for 15 minutes 30 minutes before surgery with a hot air blowing device in accordance with the normothermia care package so that the body temperature is 36-37 C°. Active heating during surgery will be done with a heating bed placed on the operating table. Patients taken to the postoperative care unit will continue to be heated with a hot air blower and the device will be turned off when the body temperature reaches 37 C°.

  • Behavioralpasive heating

    In accordance with the normothermia care package, the reflective blanket will be covered to cover the whole body 30 minutes before surgery. During the operation, the body will be covered with a reflective blanket in accordance with the surgical intervention. Patients taken to the postoperative care unit will continue to be warmed with reflective blankets.

06

What researchers measure

Primary outcomes

  1. vital signs observation form

    in this form body temperature value will be evaluated

    Time frame: Before surgery, during surgery, first 24 hours after surgery and first 3 days after surgery

  2. vital signs observation form

    In this form, diastolic and systolic blood pressure will be evaluated

    Time frame: Before surgery, during surgery, first 24 hours after surgery and first 3 days after surgery

  3. vital signs observation form

    in this form thermal comfort score will be evaluated. Thermal comfort scale evaluation will be evaluated with a visual analog scale. It is a scale with 10 points at one end of the scale and 100 points at the other end. The patient will be asked to mark his/her comfort level.

    Time frame: Before surgery, during surgery, first 24 hours after surgery and first 3 days after surgery

  4. vital signs observation form

    in this form level of tremor will be evaluated.The tremor level evaluation form is evaluated between 0-3. 0 points: no tremor, 1 Mild: tremor localized only in the neck and/or thorax, 2 Moderate: tremor in the neck, thorax and upper extremities, 3 Severe: It is evaluated as tremors in the trunk, upper and lower extremities.

    Time frame: Before surgery, during surgery, first 24 hours after surgery and first 3 days after surgery

  5. vital signs observation form

    in this form heart rate will be evaluated

    Time frame: Before surgery, during surgery, first 24 hours after surgery and first 3 days after surgery

Secondary outcomes

  1. bleeding follow-up form

    Hb (hemoglobin) will be evaluated in terms of bleeding.

    Time frame: first 3 days after surgery

  2. bleeding follow-up form

    Hct (Hemotocrit)will be evaluated in terms of bleeding.

    Time frame: first 3 days after surgery

  3. bleeding follow-up form

    PT(Protrombin time) will be evaluated in terms of bleeding.

    Time frame: first 3 days after surgery

  4. drain follow-up form

    the amount of drainage will be evaluated for bleeding

    Time frame: first 3 days after surgery

  5. observation form assessing surgical site infection

    WBC (White Blood Count) will be evaluated for surgical site infection

    Time frame: To be evaluated on the 3rd day, 10th day and 30th day after surgery

  6. observation form assessing surgical site infection

    CRP (C Reaktif Protein)will be evaluated for surgical site infection

    Time frame: To be evaluated on the 3rd day, 10th day and 30th day after surgery

  7. observation form assessing surgical site infection

    will be evaluated for surgical site infection

    Time frame: To be evaluated on the 3rd day, 10th day and 30th day after surgery

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06454877
Lead sponsor
Istanbul Saglik Bilimleri University
Responsible party
Gulsen Ozturk Genc (PhD Student, Istanbul Saglik Bilimleri University) — Principal investigator
First posted
Jun 12, 2024
Start date
Jun 1, 2024 (estimated)
Primary completion
Sep 1, 2024 (estimated)
Completion
Jun 1, 2025 (estimated)
Last update
Jun 12, 2024

Study contacts

Gülşen Genç
Contact
gulsenozturkgenc@gmail.com
05054464381

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion